Characteristic | No disordered eating (n = 177) | Disordered eating (n = 51) | P value |
---|---|---|---|
Demographics, n (%) | |||
Female | 141 (79.7) | 42 (82.4) | 0.67 |
Age | 14 (12–15) | 15 (13–16) | < 0.01 |
Race | |||
White | 138 (78.0) | 39 (76.5) | 0.80 |
Black | 10 (5.7) | 4 (7.8) | |
Other | 29 (16.4) | 8 (15.7) | |
Clinical Characteristics, n (%); median (IQR) | |||
Duration of symptoms (months) | 12 (7–36) | 24 (12–36) | 0.25 |
Pain frequency | |||
Intermittent | 27 (15.3) | 6 (11.8) | 0.65 |
Constant | 138 (78.0) | 44 (86.3) | |
Intermittent and constant | 9 (5.1) | 1 (2.0) | |
Trigger event | 68 (38.4) | 14 (27.5) | 0.15 |
BMI (kg/m2) | |||
Underweight (<5th percentile) | 2 (1.2) | 3 (6.0) | 0.08 |
Normal weight (5th- <85th percentile) | 93 (54.1) | 27 (54.0) | 0.99 |
Overweight (85th- <95th percentile) | 35 (20.4) | 7 (14.0) | 0.31 |
Obese (≥95th percentile) | 42 (24.4) | 13 (26.0) | 0.82 |
Widespreadness of pain (WPI) | 5 (1–9) | 7 (3–12) | 0.03 |
Symptom severity score | 6 (3–7) | 7 (5–9) | 0.001 |
Beighton Score (0–9) | 0 (0–2) | 0 (0–2) | 0.96 |
Patient Reported Outcomes, n (%), median (IQR) | |||
Allodynia | 152 (85.9) | 45 (88.2) | 0.67 |
Attending school full time | 117 (66.1) | 22 (43.1) | < 0.01 |
Fatigue | 81 (45.8) | 33 (64.7) | 0.02 |
Energy level (0–100%) | 70 (50–87) | 50 (33–75) | < 0.01 |
Abdominal pain | 65 (36.7) | 38 (74.5) | < 0.001 |
Dizziness | 63 (35.6) | 26 (51.0) | 0.05 |
Pain (VAS) | 60.5 (36–73) | 67.5 (40–73) | 0.27 |
Total body pain | 43 (24.3) | 21 (41.2) | 0.02 |
Functional disability (FDI) | 23 (14–31) | 32.5 (20–39) | < 0.001 |
Pain made worse by eating | 4 (2.3) | 6 (11.8) | 0.01 |
Medical Interventions, n (%) | |||
Evaluated by gastroenterologist | 46 (26.0) | 22 (43.1) | 0.02 |
Endoscopy | 28 (15.8) | 16 (31.4) | 0.01 |
Colonoscopy | 20 (11.3) | 11 (21.6) | 0.06 |
Upper gastrointestinal study | 17 (9.6) | 13 (25.5) | < 0.01 |
Evaluated by dietician | 10 (5.7) | 11 (21.6) | 0.001 |
Medical and Psychological Comorbidities, n (%) | |||
Anxiety | 78 (44.1) | 34 (66.7) | < 0.01 |
Depression | 47 (26.6) | 25 (49.0) | < 0.01 |
Suicidality | 26 (14.8) | 22 (44.0) | < 0.001 |
Conversion disorder | 11 (6.3) | 2 (4.0) | 0.41 |
Constipation | 3 (1.7) | 2 (3.9) | 0.31 |
Reflux/gastroesophageal reflux disease (GERD) | 3 (1.7) | 6 (11.8) | < 0.01 |
Inflammatory bowel disease (IBD) | 2 (1.1) | 4 (7.8) | 0.02 |
Irritable bowel syndrome (IBS) | 0 (0.0) | 6 (11.8) | < 0.001 |